FeesSafety
Pluang+

AMD's Nov 3 earnings report will test if it can sustain a $1 trillion valuation amid strong AI-driven growth.

Company Fundamentals
29 Oct 2026, 12:34 WIB
24/7 Wall Street
View Source
Bullish
AMD's Nov 3 earnings report will test if it can sustain a $1 trillion valuation amid strong AI-driven growth.

AMD's stock has surged over 165% this year, nearing a $1 trillion market cap as it reports Q3 earnings on Nov 3. Last quarter, AMD posted a 50.1% revenue increase, driven by strong data center sales and AI demand, but the stock cooled recently. Investors will watch for updates on Helios shipments, EPYC supply, and Q4 guidance to see if AMD can maintain its valuation. The company's ability to meet high expectations amid tight supply and competitive pressures will be crucial for sustaining growth into 2027.

AMD's market cap is nearing $1 trillion as it prepares to report Q3 earnings on Nov. 3. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 15:51 WIB: out of 150 priced US tech stocks, 25 rose and 122 fell. Notable movers include HUBS at USD 233.17 with a -6.21% change, ZS at USD 240.11 with 14% Sell / 86% Buy order activity, and NBIS at USD 171.41 with 33% Sell / 67% Buy order activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
16 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
16 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App